Novel glyproline GZK-111 with neuropsychotropic activity
Thе article represents a review of our own researches, which describes the design, synthesis and pharmacological properties of linear substituted glyproline GZK-111, a potential drug for the complex treatment of psychiatric pathologies, including anxiety, depressive disorders, and cognitive impairme...
Saved in:
Main Authors: | K. N. Koliasnikova, A. G. Alyaeva, E. A. Kuznetsova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC “Publisher OKI”
2022-02-01
|
Series: | Фармакокинетика и Фармакодинамика |
Subjects: | |
Online Access: | https://www.pharmacokinetica.ru/jour/article/view/294 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative study of pharmacokinetics and enzymatic resistance of the neuroprotective mean GZK-111 and noopept in rats
by: S. S. Boyko, et al.
Published: (2022-12-01) -
The <i>in vitro</i> neuroprotective activity of analogues of N-terminus substituted glyprolines
by: S. V. Nikolaev, et al.
Published: (2020-12-01) -
HPLC-MS method development and validation for simultaneous quantitation of GZK-111 and CPG compounds in rat plasma
by: A. L. Podolko, et al.
Published: (2020-04-01) -
Preferential orientation of diamond formation on TaC: Diamond(111)//TaC(111)
by: Shaohua Lu, et al.
Published: (2024-12-01) -
Monte Carlo investigation of S-values for 111In radionuclide therapy
by: Masoud Jabbari, et al.
Published: (2023-12-01)